E
ExpreS2ion Biotech Holding AB
STO:EXPRS2
ExpreS2ion Biotech Holding AB
STO:EXPRS2
Price:
1.255
SEK
-2.33%
Market Closed
Market Cap:
kr29.8m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
ExpreS2ion Biotech Holding AB
STO:EXPRS2
|
SE |
|
T
|
Tyler Technologies Inc
F:TYP
|
US |
|
Yangtze Optical Fibre and Cable Joint Stock Ltd Co
F:1YO
|
CN |
|
T
|
Toll Brothers Inc
XMUN:TLK
|
US |
|
L
|
Lloyds Banking Group PLC
F:LLD2
|
UK |
|
L
|
Lloyds Banking Group PLC
XMUN:LLD
|
UK |
|
F
|
Ford Motor Co
DUS:FMC1
|
US |
|
C
|
Canadian National Railway Co
XMUN:CY2
|
CA |
|
C
|
CCL Industries Inc
OTC:CCLLF
|
CA |
|
Moens Bank A/S
CSE:MNBA
|
DK |
Wall St Price Targets
EXPRS2 Price Targets Summary
ExpreS2ion Biotech Holding AB
ExpreS2ion Biotech Holding AB
Wall Street analysts forecast EXPRS2 stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for EXPRS2 is 5.1 SEK with a low forecast of 5.05 SEK and a high forecast of 5.25 SEK.
Lowest Forecast
Price Target
5.05
SEK
302% Upside
Average Forecast
Price Target
5.1
SEK
306% Upside
Highest Forecast
Price Target
5.25
SEK
318% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is EXPRS2's stock price target?
Price Target
5.1
SEK
5.1
SEK
According to Wall Street analysts, the average 1-year price target for EXPRS2 is 5.1 SEK with a low forecast of 5.05 SEK and a high forecast of 5.25 SEK.
What is the Revenue forecast for ExpreS2ion Biotech Holding AB?
Projected CAGR
39%
39%
The compound annual growth rate for Revenue over the next 3 years is 39%.
